The Use of Immune Regulation in Treating Head and Neck Squamous Cell Carcinoma (HNSCC)
Immunotherapy has emerged as a promising new treatment modality for head and neck cancer, offering the potential for targeted and effective cancer management. Squamous cell carcinomas pose significant challenges due to their aggressive nature and limited treatment options. Conventional therapies suc...
Auteurs principaux: | , , , , |
---|---|
Format: | Article |
Langue: | English |
Publié: |
MDPI AG
2024-02-01
|
Collection: | Cells |
Sujets: | |
Accès en ligne: | https://www.mdpi.com/2073-4409/13/5/413 |